 |
 |

Voxel-Based Morphometry in Frontotemporal Lobar Degeneration With Ubiquitin-Positive Inclusions With and Without Progranulin Mutations
Jennifer L. Whitwell, PhD;
Clifford R. Jack Jr, MD;
Matthew Baker, BS;
Rosa Rademakers, PhD;
Jennifer Adamson, BS;
Bradley F. Boeve, MD;
David S. Knopman, MD;
Joseph F. Parisi, MD;
Ronald C. Petersen, MD;
Dennis W. Dickson, MD;
Michael L. Hutton, PhD;
Keith A. Josephs, MST, MD
Arch Neurol. 2007;64(3):371-376.
Background Mutations in the progranulin gene (PGRN) have recently been identified as a cause of frontotemporal lobar degeneration with ubiquitin-positive inclusions (FTLD-U) in some families.
Objective To determine whether there is a difference in the patterns of atrophy in FTLD-U cases with and without PGRN mutations.
Design Case-control study.
Setting Brain bank of a tertiary care medical center.
Patients Eight subjects who had screened positive for PGRN mutations (PGRN-positive) and who underwent volumetric magnetic resonance imaging were identified. Subjects were then matched by clinical diagnosis to a group of 8 subjects with a pathological diagnosis of FTLD-U who had screened negative for PGRN mutations (PGRN-negative). All subjects were then age-matched and sex-matched to a control subject.
Main Outcome Measures Voxel-based morphometry was used to assess the patterns of gray matter atrophy in the PGRN-positive group compared with the PGRN-negative group and compared with controls.
Results The PGRN-positive group showed a widespread and severe pattern of gray matter loss predominantly affecting the frontal, temporal, and parietal lobes. The PGRN-negative group showed a less severe pattern of gray matter loss restricted mainly to the temporal and frontal lobes. On direct comparison, the PGRN-positive group showed greater gray matter loss in the frontal and parietal lobes compared with the PGRN-negative group.
Conclusion Findings from this study suggest that PGRN mutations may be associated with a specific and severe pattern of cerebral atrophy in subjects with FTLD-U.
Author Affiliations: Department of Radiology (Drs Whitwell and Jack), Divisions of Behavioral Neurology (Drs Boeve, Knopman, Petersen, and Josephs) and Movement Disorders (Dr Josephs), Department of Neurology, and Department of Laboratory Medicine and Pathology (Dr Parisi), Mayo Clinic, Rochester, Minn; and Divisions of Molecular Genetics (Mr Baker, Drs Rademakers and Hutton, and Ms Adamson) and Neuropathology (Dr Dickson), Department of Neuroscience, Mayo Clinic, Jacksonville, Fla.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Parietal Lobe Deficits in Frontotemporal Lobar Degeneration Caused by a Mutation in the Progranulin Gene
Rohrer et al.
Arch Neurol 2008;65:506-513.
ABSTRACT
| FULL TEXT
A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK series
Beck et al.
Brain 2008;131:706-720.
ABSTRACT
| FULL TEXT
Phenotype variability in progranulin mutation carriers: a clinical, neuropsychological, imaging and genetic study
Le Ber et al.
Brain 2008;131:732-746.
ABSTRACT
| FULL TEXT
Distinct MRI Atrophy Patterns in Autopsy-Proven Alzheimer's Disease and Frontotemporal Lobar Degeneration
Rabinovici et al.
AM J ALZHEIMERS DIS OTHER DEMEN 2008;22:474-488.
ABSTRACT
Clinical Features of Pathologic Subtypes of Behavioral-Variant Frontotemporal Dementia
Hu et al.
Arch Neurol 2007;64:1611-1616.
ABSTRACT
| FULL TEXT
|